All News

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

The Supreme Court says insurers are owed $12 billion under the Affordable Care Act; a study finds those with cancer are at higher risk from coronavirus disease 2019 (COVID-19); a survey shows millions would avoid seeking care for COVID-19 due to cost.

A new review article finds patients who suffer from psoriatic arthritis (PsA) face a higher risk of type 2 diabetes (T2D), though the exact reasons for the linkage are not yet clear.

Overall, biosimilar rituximab was used in more than 50% of patients, both as first-line therapy, second line or later.

In a commentary published in Multiple Sclerosis and Related Disorders, experts addressed common concerns individuals with multiple sclerosis (MS) might have when it comes to the coronavirus disease 2019 (COVID-19) pandemic and the use of disease-modifying therapies (DMTs).

According to 2015 CDC data, current viral suppression rates from antiretroviral therapy (ART) leave room for improvement among both HIV-positive individuals who are aware of their disease status and those receiving care, at 40.0% and 81.5%, respectively.

Incorporation of remote electrical neuromodulation into usual care reduced migraineurs’ use of acute migraine medication, potentially decreasing the risk of medication overuse headache, according to a study published in Frontiers in Neurology.

Outcomes were worse for patients with multiple myeloma (MM) and extramedullary disease, and the authors said their findings indicate that evaluation of extramedullary response using imaging is needed in this group.

Compared with patients who have just sleep apnea syndrome (SAS), those with both SAS and restless leg syndrome were shown to exhibit a higher degree of insomnia-specific psychological symptoms, which may indicate the benefit of cognitive behavioral therapy in these populations, according to study findings.

The risk of both heart attack and stroke increases 2- to 3-fold among individuals with comorbid diabetes and cardiovascular issues; however, recent study results show improved odds of both not occurring, as well as less of a risk of hospitalization for heart failure or lower extremity amputation.

A new pooled analysis of rituximab/bendamustine and rituximab/cytarabine in transplant-eligible patients with mantle cell lymphoma (MCL) finds it leads to durable positive results in most patients.

Investigators still have a lot to learn about the links among psoriatic arthritis, inflammation, and depression, but a growing body of evidence suggests significant interplay.

Preliminary data from a National Institutes of Health (NIH) clinical trial show Gilead Sciences' remdesivir accelerates recovery in patients with advanced coronavirus disease 2019 (COVID-19) infections.

In an opinion article published in JAMA Neurology, researchers discuss how the coronavirus disease 2019 (COVID-19) pandemic has transformed neurologic care more than any other crisis in modern history.

Racial disparities are a leading factor in the impact of pollution on concentrated populations; Pfizer could begin initial testing of its coronavirus vaccine as soon as next week; study results of a new liquid biopsy point to the ability to detect cancers before they have spread.

Preexposure prophylaxis (PrEP) was first approved by the FDA in 2012, but only for use among adults. An indication was added in 2018 for its use among adolescents.

Retinal displacement may be more severe and occurs more frequently in patients who undergo pars plana vitrectomy as opposed to pneumatic retinopexy for rhegmatogenous retinal detachment repair, according to a study published in JAMA Ophthalmology.

Recent study results show that patients with cancer who develop coronavirus disease 2019 (COVID-19) are far more likely to die than those who develop COVID-10 but do not have cancer. Patients being treated with immunotherapy appear to be at particularly high risk.

Compared with patients with low stress, patients with chronic obstructive pulmonary disease (COPD) and high stress had doubled odds of using acute care services, a new study found.

In new data from the phase 3 EMBRACA trial presented yesterday at the American Association for Cancer Research annual meeting, researchers found that PARP inhibitor talazoparib exhibited no statistically significant benefit in the secondary end point of overall survival in patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes.

Poor sleep quality may directly increase the headache-related impact in both patients with migraine and patients with tension-type headache, according to a study published in the Journal of Clinical Neurology. Poor sleep quality may also indirectly increase headache frequency and severity in patients with migraine.

Experts from Florida Cancer Specialists cover how the COVID-19 pandemic is transforming telemedicine in oncology by addressing billing, operations, training and provider perspectives in this webinar presented on Monday, April 20, 2020.

A new Gallup poll found that 1 of 7 Americans (14%) reported they would avoid seeking healthcare for a fever and dry cough—common symptoms of the coronavirus disease 2019 (COVID-19)—for themselves or a family member due to cost concerns. Totaled, this percentage amounts to millions of Americans.

Sachin Jain, chief executive officer of CareMore and Aspire Health, announced he will step down from both companies; HHS launches a new coronavirus disease 2019 (COVID-19) Uninsured Program Portal; evidence suggests surgical mask use among healthcare workers are putting them at risk of COVID-19 infection.

The US Supreme Court ruled in favor of health insurers seeking $12 billion from the federal government under the risk corridors program set up by the Affordable Care Act (ACA).

The lipid dioleoyl-phosphatidylglycerol accelerates healing of corneal epithelial wounds, according to a study published in Investigative Ophthalmology & Visual Science.

Delayed school start times were shown to increase sleep duration among adolescents and lessen the need for catch-up sleep during the weekend, which may assist in addressing nationwide sleep deficits in these populations.

According to the most recent PwC Health Research Institute Consumer Survey results, the top consumer concerns for the post–coronavirus disease 2019 (COVID-19) period are overall health and financial well-being, with 32% saying health-related spending adjustments have already occurred or are in the planning stages.